Humedix Co., Ltd.

KOSDAQ 200670.KQ

Humedix Co., Ltd. Shareholders' Equity for the year ending December 31, 2023: USD 152.11 M

Humedix Co., Ltd. Shareholders' Equity is USD 152.11 M for the year ending December 31, 2023, a 38.41% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.

Humedix Co., Ltd. Shareholders' Equity for the year ending December 31, 2022 was USD 109.90 M, a 4.21% change year over year.
Humedix Co., Ltd. Shareholders' Equity for the year ending December 31, 2021 was USD 105.45 M, a -4.33% change year over year.
Humedix Co., Ltd. Shareholders' Equity for the year ending December 31, 2020 was USD 110.22 M, a 14.06% change year over year.
Humedix Co., Ltd. Shareholders' Equity for the year ending December 31, 2019 was USD 96.63 M, a 1.84% change year over year.

Key data

Date	Shareholders' Equity	Minority Interest	Total Equity	Total Stockholders Equity and Liabilities

KOSDAQ: 200670.KQ

Humedix Co., Ltd.

CEO	Jin-hwan Kim
IPO Date	Dec. 26, 2014
Location	South Korea
Headquarters	603, 268, Hagui-ro
Employees	226
Sector	Consumers Staples
Industries Personal Care Biotechnology Cosmetics Dental Care Drugstores & Retail Pharmacies Eyewear Non-Alcoholic Beverages Pharmaceuticals

Description

Humedix Co., Ltd., a healthcare company, researches, develops, manufactures, and sells various pharmaceutical products in South Korea. It offers over-the-counter drugs, prescription medicines, active pharmaceutical ingredients, medical devices, cosmetic products, and functional synthetic materials, as well as health functional foods. The company was formerly known as HVLS Co., Ltd. and changed its name to Humedix Co., Ltd. in 2010. The company was founded in 2002 and is headquartered in Anyang-si, South Korea.

Key trends

Past 5 years